Brief: InDex Pharmaceuticals Q3 EBIT SEK -42.1 Million

Flerie AB

28/11/2023 07:01

Nov 28 (Reuters) - InDex Pharmaceuticals Q3 sales SEK 0.
* Q3 net income SEK -37.9 million
* Q3 cash flow from operating activities SEK -47.8 million
* Q3 adjusted EPS SEK -0.07